New data: Global oral bone graft materials market to grow at 5.3% CAGR from 2026 to 2035, with Asia-Pacific holding 32% market share

Source: Oral Bone Implant Materials Market Report

DentalGoodNews｜IndexBox released an oral bone implant material market report on October 17, forecasting that under the baseline scenario, the global market will register a compound annual growth rate (CAGR) of 5.3% from 2026 to 2035, with the market index reaching approximately 168 by 2035 (with 2025 as the baseline of 100).

According to the report, demand is diverging into two categories: one driven by public healthcare budgets and Dental Service Organizations (DSOs), characterized by high volume and price sensitivity; the other driven by aesthetic dentistry, with greater emphasis on recovery speed. In the value tier, penetration of private labels and generic materials is accelerating, putting pressure on established brands.

Source: Oral Bone Implant Materials Market Report

In terms of end-demand structure, IndexBox estimates that private clinics and group practices account for 38%, DSOs and Group Purchasing Organizations (GPOs) for 27%, hospitals and oral and maxillofacial surgery for 18%, academic and research institutions for 10%, and government clinics, non-governmental organizations and public health programs for 7%. The first two channels combined account for 65% (summed from the report's shares).

Material selection logic differs across channels. According to the report, clinicians at private clinics tend to select materials based on healing time, handling characteristics and aesthetic outcomes; DSOs and GPOs procure centrally, preferring products that meet clinical benchmarks and offer high cost-effectiveness, and require bundled supply of implants, bone graft materials and surgical instruments, with penetration expected to rise first in North America and Europe, followed by emerging markets; hospitals and oral and maxillofacial surgery departments place greater emphasis on regulatory compliance, clinical evidence and sterility assurance, with lower price sensitivity than DSOs.

Source: Oral Bone Implant Materials Market Report

Regionally, the report estimates that Asia-Pacific, North America and Europe together account for 84% of global demand. According to the report, Asia-Pacific will contribute the largest incremental volume, while North America and Europe remain the regions with the highest value contribution; the shares are labeled as regional demand shares, and the report does not specify whether they are calculated by value or by volume. Regional shares and characteristics described in the report are as follows:

Asia-Pacific is estimated at a 32% share. According to the report, implant penetration is rising in China, India and Southeast Asia, with the fastest volume growth; the region is price-sensitive, favoring the value tier and local brands, while premium penetration in urban areas is increasing. North America is estimated at a 28% share, and the report states it remains the largest value pool. DSO consolidation is accelerating, patient-driven premium demand is increasing, and private labels continue to penetrate the value tier.

Europe is estimated at a 24% share. Germany, Switzerland and the Nordic countries have strong premium segments; public healthcare cost controls have constrained value-tier growth, while the premium segment maintains steady growth. Latin America is estimated at a 9% share. Brazil and Mexico lead, with high price sensitivity, and private clinic investment supports gradual premiumization. The Middle East and Africa is estimated at a 7% share. Medical tourism in Gulf countries and public health expansion in some African countries are driving development, while cost sensitivity and limited reimbursement constrain premium products.

In terms of innovation direction, the report states that the focus is shifting toward patient-facing claims such as "shorter healing time" and "minimally invasive applications," reflecting the consumerization trend in elective oral surgery. Technological iteration of synthetic materials and biphasic calcium phosphate systems is cited as one of the demand drivers; minimally invasive bone grafting requires flowable or moldable materials. Hospital applications include digital surgical planning and 3D Printing, while academic research includes growth factor delivery and 3D Printing of personalized scaffolds.

On the supply side, the report notes that raw material suppliers are consolidating, pathogen-free sourcing requirements for xenograft materials are becoming stricter, and supply chain constraints exist for xenograft raw materials and medical-grade calcium phosphate powders. Regarding cost and profit, penetration of private labels and generic materials in the value tier will compress average selling prices and margins for standardized products; reimbursement limits in public healthcare systems and patient out-of-pocket sensitivity constrain adoption of premium products.

IndexBox: Oral Bone Implant Material Market Forecast to 2035, updated October 17, 2026; archive page: [Primary Source] IndexBox - Oral Bone Implant Material Market Forecast to 2035 SHANGHAI HILE BIO-TECHNOLOGY CO., LTD. Reply Announcement on the Regulatory Work Letter from the Shanghai Stock Exchange Regarding the Acquisition of Minority Equity in a Subsidiary by SHANGHAI HILE BIO-TECHNOLOGY CO., LTD., HILE Announcement, December 2025; previous DGN report: Ruisheng Biology Oral Bone Graft and Membrane Product Unit Price Rose 45% Month-on-Month in November "Announcement on Acquisition of Partial Equity in Xi'an Salamander Biotechnology Co., Ltd. and Partial Property Shares in Xi'an Huicai Enterprise Management Consulting Partnership (Limited Partnership) by Xi'an Kangtuo Medical Technology Co., Ltd." [2025] [China] [Kontour(Xi'an) Medical Technology Co.,Ltd.], Kontour Medical Announcement, August 29, 2025; previous DGN report: Kontour Medical Plans to Acquire Controlling Stake in Xi'an Salamander Biotechnology for RMB 85 Million, Expanding into Oral Regenerative Materials, September 2, 2025